Analysis Note
The sensitivity is ~0.1 ng/mL, 20 times more sensitive than immunoblotting.
Application
Designed for the quantitative determination of human retinoblastoma (Rb).
General description
A solid phase sandwich enzyme-linked immunosorbent assay (ELISA).
Application
Rb ELISA is designed for the quantitative detection of Rb in human cell lysates independent of its phosphorylation state. It may be used to normalize the results of Phospho-Rb (pSer249/pThr252) ELISA (CS0060).
Biochem/physiol Actions
Rb, the tumor suppressor product of the retinoblastoma susceptibility gene, is a 110 kDa protein that plays an important role in regulating cell growth and differentiation. The cell cycle inhibitory function is abrogated when Rb undergoes phosphorylation, catalyzed by the complex of cyclins/cyclin-dependent protein kinases (cdks).
Features and Benefits
The kit offer a fast (total assay time 4 hours), sensitive (sensitivity 0.1 ng/mL for non-phosphorylated and <0.8 units/mL for phosphorylated Rb) and easy alternative to immunoblotting or other bioassays. Precoated plates are provided in the kit, incubations proceed at room temperature and no proprietary equipment is required.